<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399788</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-8835</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Health science reports</Title><ISOAbbreviation>Health Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Depression and related factors among patients with post-COVID-19 conditions: Cross-sectional, hospital-based study.</ArticleTitle><Pagination><StartPage>e70142</StartPage><MedlinePgn>e70142</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70142</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/hsr2.70142</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="UNASSIGNED">The COVID-19 crisis has significantly impacted public health, particularly mental health. This study aims to determine the prevalence of depression and related factors among patients with post-COVID-19 conditions in an outpatient clinic at a tertiary referral hospital in Southern Vietnam.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A cross-sectional survey was conducted among 410 patients with post-COVID-19 conditions in an outpatient clinic at the University Medical Center Ho Chi Minh City. A convenience sampling method was used to screen for depression using the Patient Health Questionnaire-9 (PHQ-9).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 410 patients participated in the study. Depression was observed in 23.7% of respondents, categorized as mild (80.4%), moderate (16.5%), or severe (3.1%) based on PHQ-9 scores. Factors influencing depression included age 50 years or older, religion, education level, full-time employment, marital status, family contact, use of anti-inflammatory drugs, hospital admission due to COVID-19, chronic diseases, hypertension, and post-COVID-19 symptoms (shortness of breath, palpitations, fatigue, headache, abdominal pain, brain fog, insomnia, and loss of appetite). The most common symptoms reported were cough, dyspnea, shortness of breath, fatigue, and loss of appetite. A <i>p</i>-value of less than 0.05 indicated statistical significance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The prevalence of depression among patients with post-COVID-19 conditions in the outpatient clinic was high. Improving mental health and quality of life, alongside the prevention and treatment of COVID-19, should remain public health priorities.</AbstractText><CopyrightInformation>© 2024 The Author(s). Health Science Reports published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Binh</LastName><ForeName>Nguyen Thanh</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Public Health Faculty of Medicine, Tra Vinh University Tra Vinh Tra Vinh Province Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thuan</LastName><ForeName>Tran Thien</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Health Education-Medical Psychology Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City Ho Chi Minh City Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luc</LastName><ForeName>Nguyen Hoang Tan</ForeName><Initials>NHT</Initials><AffiliationInfo><Affiliation>Department of Disease Control Medical Center of Tan Phu District Ho Chi Minh City Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>Ho Tat</ForeName><Initials>HT</Initials><Identifier Source="ORCID">0000-0002-6786-1644</Identifier><AffiliationInfo><Affiliation>Thoracic and Vascular Department University Medical Center HCMC, University of Medicine and Pharmacy at Ho Chi Minh Ho Chi Minh City Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deparment of Health Management Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City Ho Chi Minh City Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Le Thi Diem</ForeName><Initials>LTD</Initials><AffiliationInfo><Affiliation>Department of Community Health Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City Ho Chi Minh City Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Health Sci Rep</MedlineTA><NlmUniqueID>101728855</NlmUniqueID><ISSNLinking>2398-8835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PHQ‐9</Keyword><Keyword MajorTopicYN="N">cross‐sectional</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">hospital‐based</Keyword><Keyword MajorTopicYN="N">post‐COVID‐19 condition</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399788</ArticleId><ArticleId IdType="pmc">PMC11466829</ArticleId><ArticleId IdType="doi">10.1002/hsr2.70142</ArticleId><ArticleId IdType="pii">HSR270142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bueno‐Notivol J, Gracia‐García P, Olaya B, Lasheras I, López‐Antón R, Santabárbara J. Prevalence of depression during the COVID‐19 outbreak: a meta‐analysis of community‐based studies. Int J Clin Health Psychol. 2021;21:100196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458054</ArticleId><ArticleId IdType="pubmed">32904715</ArticleId></ArticleIdList></Reference><Reference><Citation>Huremović D. Social Distancing Q, and Isolation.  In: Huremović D. (ed.). Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak. Vol 61. Springer International Publishing; 2020:85‐94.</Citation></Reference><Reference><Citation>Pfefferbaum B, North CS. Mental health and the Covid‐19 pandemic. N Engl J Med. 2020;383:510‐512.</Citation><ArticleIdList><ArticleId IdType="pubmed">32283003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID‐19 pandemic. JAMA Network Open. 2020;3:e2019686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489837</ArticleId><ArticleId IdType="pubmed">32876685</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO‐MOH V . Viet Nam COVID‐19 Situation Report #109 Epidemiological report as of 31 May 2023, 18:00 . 2023.</Citation></Reference><Reference><Citation>Tran QD, Vu TQC, Phan NQ. Depression prevalence in Vietnam during the Covid‐19 pandemic: a systematic review and meta‐analysis. Ethics Med Public Health. 2022;23(2022):100806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9162960</ArticleId><ArticleId IdType="pubmed">35676918</ArticleId></ArticleIdList></Reference><Reference><Citation>Méndez R, Balanzá‐Martínez V, Luperdi SC, et al. Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors. J Intern Med. 2021;290:621‐631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TQ, Bandeen‐Roche K, Bass JK, German D, Nguyen NTT, Knowlton AR. A tool for sexual minority mental health research: the patient health questionnaire (PHQ‐9) as a depressive symptom severity measure for sexual minority women in Viet Nam. J Gay Lesbian Ment Health. 2016;20:173‐191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5019570</ArticleId><ArticleId IdType="pubmed">27642381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y‐F LW, Li W, Deng HB, et al. Prevalence of depression and its association with quality of life in clinically stable patients with COVID‐19. J Affect Disord. 2020;275:145‐148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7329672</ArticleId><ArticleId IdType="pubmed">32658818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID‐19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17:1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084952</ArticleId><ArticleId IdType="pubmed">32155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Ferdous MZ, Islam US, Mosaddek ASM, Potenza MN, Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID‐19 in Bangladesh. Int J Environ Res Public Health. 2021;18:1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues M, Costa AJ, Santos R, et al. Inpatient rehabilitation can improve functional outcomes of post‐intensive care unit COVID‐19 patients‐a prospective study. Disabil Rehabil. 2023;45:266‐276.</Citation><ArticleIdList><ArticleId IdType="pubmed">35133225</ArticleId></ArticleIdList></Reference><Reference><Citation>
Health VMo
. To maintain effective protection, it is necessary to receive the 3rd and 4th doses of the COVID‐19 vaccine. 2022. Accessed November 2, 2023. https://moh.gov.vn/tin-tong-hop/-/asset_publisher/k206Q9qkZOqn/content/thu-truong-bo-y-te-e-duy-tri-hieu-qua-bao-ve-can-phai-tiem-vaccine-phong-covid-19-mui-3-mui-4
</Citation></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post‐COVID‐19 manifestations. Int J Clin Pract. 2021;75:e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID‐19 in a multistate health care systems network ‐ United States, March‐June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993‐998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, et al. Follow up of patients with severe coronavirus disease 2019 (COVID‐19): pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID‐19. JAMA. 2020;324:603‐605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel SAM OHT, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Postacute and long‐COVID‐19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2021;39:159‐167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Goërtz YMJ VHM, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS‐CoV‐2 infection: the post‐COVID‐19 syndrome? ERJ Open Res. 2020;6:00542‐2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SX, Chen RZ, Xu W, et al. A systematic review and meta‐analysis of symptoms of anxiety, depression, and Insomnia in Spain in the COVID‐19 crisis. Int J Environ Res Public Health. 2022;19(2):1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775436</ArticleId><ArticleId IdType="pubmed">35055841</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID‐19). Clin Infect Dis. 2021;73:e1089‐e1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>